A Ground's-Eye View on Racial and Ethnic Disparities in Cancer Clinical Trial Participation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Feasibility of EHR-based prescreening for an adjuvant breast cancer trial in a safety-net health system.The oncologist · 2026
   Article
2. Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globally.Journal of the National Cancer Institute. Monographs · 2025
   Article
3. Overcoming challenges of recruiting cancer patients into clinical trials: insights from a randomized trial of app-based smoking cessation interventions.American journal of cancer research · 2025
   Article
4. National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
   Article

Corrections and comments

• Comment on
  Racial and Ethnic Inequities in US Oncology Clinical Trial Participation From 2017 to 2022.2023

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as